Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We are "owed" a CC this quarter!
Excellent points Denny, NYDFS possible progress and possible larger Greenpoint settlement (with Lehman weaseling off the hook for much). Great discussion on the board this weekend guys!
The median tmax of OC was statistically significantly delayed (2 hours) under high-fat fed versus fasted conditions (P<0.02). There was no statistically significant difference in tmax under low-fat fed conditions versus fasted conditions.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145823/
What's the FDA's beef? Besides an ADF oxy, does Elite have to improve the original formulation of IR Oxy, too?
How does this compare with SequestOx?
For the IR solution, both oxycodone bioavailability and peak plasma oxycodone concentration were significantly altered by consumption of the high-fat meal, with the mean value for AUC0-infinity increasing to 120% (CI = 109-132%) and the mean value for Cmax decreasing to 82% (CI = 47-91%) of values observed in the fasted condition. Adverse events reported for both formulations were mostly mild to moderate in severity and typical of those observed with opioids.
http://www.ncbi.nlm.nih.gov/pubmed/8901078
GLTU Hose! And thanks again for originally getting me interested in Syncora years ago on the MBIA yahoo MB! Hope you can retire soon and give your knees a well-deserved rest.
Have a nice weekend! Hope this news helps propel the stock's continued breakout on Monday! Sent Denny a message on Twitter, but perhaps he's in the air and doesn't have access... know the news would be of great interest to him and others.
As a side note, just noticed that our favorite poster BunkMoreland has been banned from the board. He was "full of it," but had to like his colorful lingo :)
53.32 million this week!!! And still pending:
This settlement is separate and distinct from the U.S. Bank National Association, as Indenture Trustee v. GreenPoint Mortgage Funding, Inc. action, with respect to, among other things, alleged breaches of representations and warranties by GreenPoint, which remains pending in state court.
Guess Lincoln we are the only ones still hanging around after market hours on a Friday...
Is that 37 million or 36% of?
And how about this?
This settlement is separate and distinct from the U.S. Bank National Association, as Indenture Trustee v. GreenPoint Mortgage Funding, Inc. action, with respect to, among other things, alleged breaches of representations and warranties by GreenPoint, which remains pending in state court.
Looks like Syncora is a cash cow!!! Guess this news didn't leak...
HAMILTON, Bermuda, July 22, 2016 /PRNewswire/ – Syncora Holdings Ltd. ("SHL" or the "Company") today announced that its wholly owned, New York financial guarantee insurance subsidiary, Syncora Guarantee Inc. ("SGI"), has reached an agreement in principle for the settlement of its sole existing claim and related litigation with Lehman Brothers Holdings Inc. and Structured Asset Securities Corporation ("Sasco"). If consummated, the terms of the settlement will resolve all claims in respect of SGI's proof of claim filed on January 13, 2010, against Lehman Brothers Holdings Inc. and Sasco in the United States Bankruptcy Court for the Southern District of New York, relating to the GreenPoint Mortgage Funding Trust 2006-HE1 transaction, in return for an allowed unsecured claim of $37 million in the Lehman bankruptcy estate. In the Notice Regarding Tenth Distribution Pursuant to The Modified Third Amended Joint Chapter 11 Plan of Lehman Brothers Holdings Inc. And Affiliated Debtors filed with the bankruptcy court on June 9, 2016, the Lehman bankruptcy estate is currently projecting cumulative payments of approximately 36 cents on the dollar to be paid on allowed unsecured claims, but that projection is subject to change. The settlement remains subject to final definitive documentation. No assurances can be made that such final definitive documentation will be entered into. If consummated, the settlement is expected to increase SHL's GAAP net income and shareholders' equity by the amount ultimately paid by the Lehman bankruptcy estate and is expected to have the same effect on SGI's statutory-basis net income and policyholders' surplus.
This settlement is separate and distinct from the U.S. Bank National Association, as Indenture Trustee v. GreenPoint Mortgage Funding, Inc. action, with respect to, among other things, alleged breaches of representations and warranties by GreenPoint, which remains pending in state court.
WeeZuhl, perhaps you should send an email to Nasrat/Diane with your idea. How about getting SequestOx approved with the applesauce label and then working on the new Oxy bead?
Thanks for the info, Denny! What is your guess to how much of it may be Syncora's?
Thanks, Denny! Guess it really doesn't matter, just curious.
It's ready to rock, fundamentals and technicals awesome. The lid could be blown off at any time.
Please let us know what you see in the report, whether something or nothing.
One other thing: when will we know for sure where the 40 million came from?
Thanks as always, Denny!
Thanks for your informative post, lasers!
Typically a breakout from a proper base pattern will rise 20-25% and then consolidate again. Currently at 1.46 we are almost 22% above the proper buy point of 1.20. For most chart patterns, consolidation would again take place for awhile at about these levels, perhaps as little as 3 weeks if a 3-weeks tight pattern forms. However, the SYCRF chart pattern is a very powerful one in which gains of 200% are possible. Not saying this will happen, but just saying ... Weekly:
Found lots of hits on google pertaining to sprinkling the contents of a capsule on applesauce and delayed reactions if consuming high-fat foods. I guess lasers you do not think the FDA will have an issue with SequestOx if sprinkled when consuming high-fat foods (and actually is quite common)? Do you think that the FDA will require a clinical trial for testing of the sprinkling? thanks
Great info, thanks again rockraider! You've been a valued asset to the board(s) ever since our days on the Yahoo MB!
Thanks rockraider! Guess there could be more in the future, just not as of yesterday.
Thanks, Denny! Excellent discussion on this board about exactly where the 40 mill came from. Hope there are more of these unexpected nuggets (or gold bars is probably more appropriate) in Syncora's future (near).
Seems like this thing really wants to take off, but something is holding it back. Finished low in the trading range last couple of days. Could be manipulation and/or short sellers. Seems there is so much value locked up in Syncora one day this thing is going to take off for good! Chart looks awesome, plus it is good to get passed the overhead resistance in the 1.20's, so maybe the liftoff will be soon:
Sounds plausible to me. What do you think Denny?
So news was leaked at about 11am ET, but most of us didn't know why the pps was skyrocketing until after close. Is a 12 cent gain enough to price in a "free" 40 million, especially since most didn't even know what was going on?
Could Syncora have anymore of these "hidden" gems? :)
Someone didn't do a good job at keeping the news quiet. Nice to get a bunch of unexpected cash!!!!
Any idea who the settlement is related to? Nice to get 40 mill for little old Syncora with its paltry 76 million market cap.
ER NDAs should be good to go. Just need to workout the details for IR. Looks likely Elite will be able to avoid another clinical trial. Good CC by Nasrat - very informative - doesn't seem like he was trying to hide anything or sugar-coat it.
Has to be more than just a tweet. Something must be going on fundamentally besides just technically. We have a lot of knowledgeable folks on this board. Doesn't someone know something? A possible buyout offer, big settlement, ... Please share with your fellow posters.
Technicals are great. Broke out of that high-tight flag pattern, which is one of the strongest patterns.
Might be right if major issue in CRL, such as another clinical trial, plus the market's typical knee-jerk, overreaction. If it's a minor issue, perhaps we could hold .20, although I have to admit that is going to be tough. Telling us what's in the CRL is definitely the right thing to do, good or bad. If they didn't tell us, market will no doubt assume bad.
Some at Elite probably read some of our pps predictions for Monday so decided to give us the info in the CRL. May as well, otherwise investors will assume the worse.
Cool that Elite sent out a PR on Saturday telling about the CC prior to market open on Monday. Hopefully they can somewhat calm anxious investors.
Interesting CRL study:
A new study by the research group Datamonitor has found that complete response letters are sent by the US Food and Drug Administration (FDA) in response to NEARLY HALF of all new drug and biologic applications (NDAs, BLAs),...
The median delay was 13 months for Class 2 (generally major) resubmissions, though those delays could be AS SHORT as 3.5 months and as long as 26 months. CLASS 1 (generally less serious) resubmissions had a median time of 4.4 months (range = 1.5 to 9.1 months).
http://www.raps.org/focus-online/news/news-article-view/article/2761/
I'm not planning on selling. Want to hear what the FDA told Elite. Growing generics biz will may sustain a pps of perhaps 8-12 cents. The market almost always overreacts, so that is why I say it is possible it will get into the single digits next week. When the market does overreact, might be good time to add a little to position, if you believe in the co for the long run.
Perhaps single digits. Probably depends on what the market values Elite's growing generics business at. If market overreacts (like it usually does), I'm thinking 8 cents or lower would be a good place to add. Sold a little last week but still hold a majority of my shares, so wouldn't mind buying my sold shares back.
The teens or perhaps a little lower
No, they have a growing generics biz. Not sure the pps that that will support, however. Things were a lot more bleak a few years ago, especially after the FDA pulled our only product from the market, Lodrane, just as we were starting to be profitable, so this isn't the first time the FDA stuck it to us. You can ask Jerry about that!
Would be awesome if it held .20, but I kind of doubt it. If it falls too low, I may add. Like to see a PR on the whys of the CRL, regardless if bad or not so much so. Market is going to price in worse can scenario so may as well tell us.